CARDIOVASCULAR DISEASE2000 WORDS  This paper utilizes qualitative data drawn from a series of focus group discussions with patients living with coronary heart disease which explored their understandin

CARDIOVASCULAR DISEASE2000 WORDS  This paper utilizes qualitative data drawn from a series of focus group discussions with patients living with coronary heart disease which explored their understandin

$0.69
Add To Cart

CARDIOVASCULAR DISEASE

2000 WORDS 

 

This paper utilizes qualitative data drawn from a series of focus group discussions with patients living with coronary heart disease which explored their understanding of and adherence to a prescribed monitoring and medication regime. These findings are drawn upon in order to contextualize, from the patient’s perspective, the outcomes of the Departments of Health’s Coronary Heart Disease National Service Framework strategy.

 

The paper focuses attention on the consequences of this regulatory approach to clinical and risk management for those patients already living with coronary heart disease.

 

Case Study

Patient is 59 yrs old and had a myocardial infarction 2 years ago. He is obese, a smoker and poorly motivated. The case exemplifies many of the difficulties that frequently arise in managing cardiovascular disease, and suggests potential avenues for improving outcomes through the application of a disease management programme.

 

The Coronary Heart Disease National Service Framework

By the mid 1980s, it had been generally accepted by most clinicians that there was strong evidence to support the existence of a linear relationship between cholesterol levels and cardiac mortality (Shaper et al. 1985, Stamler et al. 1986), and that therefore lowering total cholesterol levels would reduce the risk of individuals developing coronary heart disease.

 

This opened the way to the process of establishing a recommended cholesterol threshold level at which treatment should be instigated (Leitch 1989). Since then, the trend has been towards setting ever-lower threshold targets for treatment for those designated as being at high risk of developing